Loading...
OTCM
PBSV
Market cap10mUSD
Oct 08, Last price  
0.48USD
1D
15.36%
Jan 2017
-51.52%
IPO
23.08%
Name

Pharma-Bio Serv Inc

Chart & performance

D1W1MN
OTCM:PBSV chart
P/E
—
P/S
1.22
EPS
—
Div yield, %
15.63%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
-16.03%
Revenues
9m
-5.34%
14,229,83116,204,85115,196,39311,479,08311,346,45319,933,18229,227,16733,062,01027,555,03923,384,86119,536,71515,579,27517,797,42519,506,91121,564,36020,115,17519,398,72716,976,8569,509,2799,001,096
Net income
-100k
L-87.08%
2,335,3401,901,1671,487,796534,757371,9113,158,9814,687,0064,906,4892,413,6451,624,826-256,575-1,414,9091,279,7342,087,2562,050,922-2,089,2401,006,6841,310,180-777,619-100,463
CFO
-215k
L-62.08%
1,557,8585,628,7161,580,1062,172,531466,3492,140,2732,459,0665,626,6863,330,667372,607709,653-1,548,2083,718,684-2,207,7391,525,442804,842592,4571,890,960-566,701-214,886
Dividend
Feb 27, 20260.075 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including those in the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries, as well as related product companies. Its operational reach extends across Puerto Rico, the United States, Europe, and Brazil. The firm's technical advisory offerings encompass vital areas such as regulatory adherence, system validation, technology migration, engineering solutions, comprehensive project management, and ongoing process support. Established in 1993, Pharma-Bio Serv maintains its corporate headquarters in Dorado, Puerto Rico.

Key people

Elizabeth Plaza
Chairman of the Board · since 2015
Victor Sanchez
President, Chief Executive Officer · since 2015
Pedro J. Lasanta
Chief Financial Officer, Vice President - Finance and Administration, Secretary · since 2014
Howard Spindel
Independent Director · since 2006
Irving L. Wiesen
Independent Director · since 2006
IPO date
Nov 08, 2008
Employees
140
Domiciled in
PR
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑102024‑102023‑102022‑102021‑102020‑102019‑102018‑102017‑102016‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT